Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells

Title
Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells
Authors
Keywords
-
Journal
MOLECULAR PHARMACEUTICS
Volume 14, Issue 4, Pages 1047-1056
Publisher
American Chemical Society (ACS)
Online
2017-03-02
DOI
10.1021/acs.molpharmaceut.6b00919

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started